The EFPIA Disclosure Code provides a common basis for reporting across Europe in relation to transfers of value. For more information on this Code visit: http://transparency.efpia.eu or http://ifpa.lt/en/etikos-kodeksas-2/atskleidimo-kodeksas/

The publication of this information is made for transparency purposes only, as further detailed in the Pfizer EEA HCP Privacy Policy at https://privacycenter.pfizer.com/en/lt/hcp (section "Disclosures of transfer of value”). It does not entail a general authorisation to those accessing the website to carry out any further processing of health care professionals' (HCP’s) data, such as combining it with the information published on other websites.

According to the Law on Pharmacy of the Republic of Lithuania and the legislation implementing this law (Order No V-1537 of the Minister of Health adopted on 23 of June 2020. On the approval of the description of the procedure for the submission of information on transfers of value to recipients of transfers of value, data of legal entities and personal data of health care and/or pharmaceutical specialists to the state medicines control agency under the ministry of health of the republic of Lithuania and publication of information on transfers of value and personal data of health care and/or pharmaceutical specialists) reports about Transfer of Values (ToVs) made to HCPs and HCOs during the year 2021 are submitted by the company to the State Medicines Control Agency and will be available on www.vvkt.lt. by 30 June, 2022.

• 2021 report of values transferred related to R&D can be found here.

• 2021 report of values transferred to POs can be found here.

• 2021 Methodology notes can be found here.

• 2021 Pfizer Self Certification Scheme can be found here.

According to the Law on Pharmacy of the Republic of Lithuania and the legislation implementing this law (Order No V-1537 of the Minister of Health adopted on 23 of June 2020. On the approval of the description of the procedure for the submission of information on transfers of value to recipients of transfers of value, data of legal entities and personal data of health care and/or pharmaceutical specialists to the state medicines control agency under the ministry of health of the republic of Lithuania and publication of information on transfers of value and personal data of health care and/or pharmaceutical specialists) reports about Transfer of Values (ToVs) made to HCPs and HCOs during the year 2022 are submitted by the company to the State Medicines Control Agency and will be available on www.vvkt.lt. by 30 June, 2023.

• 2022 report of values transferred related to R&D can be found here.

• 2022 report of values transferred to POs can be found here.

• 2022 Methodology notes can be found here.

• 2022 Pfizer Self Certification Scheme can be found here.

According to the Law on Pharmacy of the Republic of Lithuania and the legislation implementing this law (Order No V-1537 of the Minister of Health adopted on 23 of June 2020. On the approval of the description of the procedure for the submission of information on transfers of value to recipients of transfers of value, data of legal entities and personal data of health care and/or pharmaceutical specialists to the state medicines control agency under the ministry of health of the republic of Lithuania and publication of information on transfers of value and personal data of health care and/or pharmaceutical specialists) reports about Transfer of Values (ToVs) made to HCPs and HCOs during the year 2023 are submitted by the company to the State Medicines Control Agency and will be available on www.vvkt.lt. by 30 June, 2024.

• 2023 report of values transferred related to R&D can be found here.

• 2023 report of values transferred to POs can be found here.

• 2023 Methodology notes can be found here.

• 2023 Pfizer Self Certification Scheme can be found here.